{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:47:17Z","timestamp":1757616437769,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2014,11,25]]},"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1136\/jfprhc-2014-101015","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T03:01:20Z","timestamp":1420686080000},"page":"81-83","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["The bitter pill"],"prefix":"10.1136","volume":"41","author":[{"given":"Lucy","family":"Cox","sequence":"first","affiliation":[{"name":"General Practitioner and Clinical Lead in Contraception, Saxonbrook Medical, Crawley, West Sussex, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,1,7]]},"reference":[{"key":"2025090511414688000_41.2.81.1","unstructured":"RFI English. French woman sues Bayer over third-generation contraceptive pill. http:\/\/www.english.rfi.fr\/americas\/20121215-french-woman-sues-bayer-over-third-generation-contraceptive-pill [accessed 15 November 2014]."},{"key":"2025090511414688000_41.2.81.2","unstructured":"Larat M . Le pilule est am\u00e8re. Paris, France: Les Editions Stock, 2013."},{"key":"2025090511414688000_41.2.81.3","unstructured":"R\u00e9pertoire des Sp\u00e9cialit\u00e9s Pharmaceutiques. M\u00e9liane: R\u00e9sum\u00e9 des caract\u00e9ristiques. 2012. http:\/\/81.93.3.45\/www_espace-bsp_fr\/produits\/ml\/meliane_ml.pdf [accessed 28 June 2014]."},{"key":"2025090511414688000_41.2.81.4","unstructured":"Le Monde . Marisol Touraine: \u201cIl faut \u00e9viter de donner le sentiment que la pilule serait un danger\u201d. http:\/\/www.lemonde.fr\/sante\/article\/2013\/01\/03\/prudence-face-a-la-panique-a-la-pilule_1812743_1651302.html [accessed 15 November 2014]."},{"key":"2025090511414688000_41.2.81.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f121"},{"key":"2025090511414688000_41.2.81.6","doi-asserted-by":"crossref","unstructured":"Guillebaud J . Contraception Today. London, UK: Informa Healthcare, 2012:22\u201327.","DOI":"10.1201\/b15065"},{"key":"2025090511414688000_41.2.81.7","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2013-100624"},{"key":"2025090511414688000_41.2.81.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.12.019"},{"key":"2025090511414688000_41.2.81.9","unstructured":"European Medicines Agency. Assessment Report for Combined Hormonal Contraceptives Containing Medicinal Products. 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Combined_hormonal_contraceptives\/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee\/WC500160272.pdf [accessed 15 November 2014]."},{"key":"2025090511414688000_41.2.81.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111840"},{"key":"2025090511414688000_41.2.81.11","unstructured":"Bayer Healthcare. Dianette: Summary of Product Characteristics update. 10 April 2014. http:\/\/www.medicines.org.uk\/emc\/medicine\/1814 [accessed 15 November 2014]."},{"key":"2025090511414688000_41.2.81.12","unstructured":"French National Agency for Medicines and Health Products Safety (ANSM), Benefit\/risk review of cyproterone acetate (2 mg) and ethinylestradiol (0.035 mg) combination containing medicinal products. 2013. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/cyproterone_ethinylestradiol_107i\/Procedure_started\/WC500139271.pdf [accessed 15 November 2014]."},{"key":"2025090511414688000_41.2.81.13","unstructured":"Europe Medicines Agency. Assessment Report Cyproterone Acetate\/Ethinylestradiol (2 mg\/0.035 mg) Containing Medicinal Products. 2013. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/cyproterone_ethinylestradiol_107i\/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee\/WC500144130.pdf [accessed 15 November 2014]."},{"key":"2025090511414688000_41.2.81.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91928-7"},{"key":"2025090511414688000_41.2.81.15","doi-asserted-by":"crossref","unstructured":"Bajos N , Rouzard-Cornabas M , Panjo H , et al . The French pill scare: towards a new contraceptive model? Population and Societies \u2013 Monthly Bulletin of the French National Institute for Demographic Studies 2014;511. http:\/\/www.ined.fr\/fichier\/s_rubrique\/19893\/population_societies_2014_511_pill_scare.en.pdf [accessed 15 November 2014].","DOI":"10.3917\/popsoc.511.0001"},{"key":"2025090511414688000_41.2.81.16","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2011-100260"},{"key":"2025090511414688000_41.2.81.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4387"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jfprhc-2014-101015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:59:02Z","timestamp":1757098742000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/jfprhc-2014-101015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,7]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,3,20]]},"published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1136\/jfprhc-2014-101015"],"URL":"https:\/\/doi.org\/10.1136\/jfprhc-2014-101015","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2015,1,7]]}}}